Physician

Adam Souhail Aldahan, MD

According to 2025 Medicare claims, Adam Aldahan, MD (NPI: 1609304617) practices dermatology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is PBD&P INC (NPI: 1689640328; TIN: 650846826) and primary practice location at 33434-3988.

Aldahan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 585 traditional Medicare patients, billed 6,956 HCPCS/CPT codes, and received $269,741 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,034 prescription claims across 461 beneficiaries totaling $213,884 in drug costs, led by Triamcinolone Acetonide (Triamcinolone Acetonide). Open Payments data shows 15 records totaling $379. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,294 to $213,884. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$135K$270K2021 Medicare payment: $32,244 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $130,525 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $115,167 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $269,741 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021118464$32,244
20224581,766$130,525
20234761,693$115,167
20245856,956$269,741

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$201K$401K2017 Drug cost: $2,294 (USD; Tot_Drug_Cst)2018 Drug cost: $2,526 (USD; Tot_Drug_Cst)2020 Drug cost: $1,436 (USD; Tot_Drug_Cst)2021 Drug cost: $19,185 (USD; Tot_Drug_Cst)2022 Drug cost: $219,445 (USD; Tot_Drug_Cst)2023 Drug cost: $401,326 (USD; Tot_Drug_Cst)2024 Drug cost: $213,884 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R18$2,294
20182246$2,526
2019N/RN/RN/R
2020N/R14$1,436
2021146217$19,185
2022443996$219,445
20236231,406$401,326
20244611,034$213,884

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more204289$96
17110Destruction of skin growth, 1-14 growths236340$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more349536$71
17000Destruction of precancer skin growth, 1 growth306433$36
17003Destruction of precancer skin growth, 2-14 growths2191,317$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Triamcinolone AcetonideTriamcinolone Acetonide2628,584$3,411
TacrolimusTacrolimus19584$2,185
KetoconazoleKetoconazole1463,958$1,988
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc681,806$1,962
MetronidazoleMetronidazole341,073$1,950

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$379GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Souhail Aldahan, MD?

Tedicare shows public-source Medicare data for Adam Souhail Aldahan, MD (NPI 1609304617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Souhail Aldahan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Souhail Aldahan, MD?

Adam Souhail Aldahan, MD is linked to PBD&P INC (billing NPI 1689640328) in the available physician profile data.

Does Adam Souhail Aldahan, MD have Open Payments data?

Adam Souhail Aldahan, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.